# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA967968 | F | Antibacterial activity against hefC-deficient Helicobacter pylori by NCCLS method | Helicobacter pylori | 17 | ALA1155910 | organism-based format | Scientific Literature | |
2. | ALA967969 | F | Antibacterial activity against wild type Helicobacter pylori by NCCLS method | Helicobacter pylori | 19 | ALA1155910 | organism-based format | Scientific Literature | |
3. | ALA967970 | B | Inhibition of Helicobacter pylori MurI | Helicobacter pylori | 19 | ALA1155910 | single protein format | Scientific Literature | |
4. | ALA967971 | A | Intrinsic clearance in mouse liver microsome | Mus musculus | 18 | ALA1155910 | microsome format | Scientific Literature | |
5. | ALA967972 | A | Intrinsic clearance in human liver microsome | Homo sapiens | 18 | ALA1155910 | microsome format | Scientific Literature | |
6. | ALA967973 | A | Bioavailability in mouse at 40 mg/kg, po | Mus musculus | 3 | ALA1155910 | organism-based format | Scientific Literature | |
7. | ALA967976 | P | Equilibrium solubility of compound | 2 | ALA1155910 | small-molecule physicochemical format | Scientific Literature | ||
8. | ALA967977 | A | Protein binding in mouse plasma | Mus musculus | 1 | ALA1155910 | cell-free format | Scientific Literature | |
9. | ALA1655024 | F | Antibacterial activity against Helicobacter pylori SS1 by CLSI M100-S13 method | Helicobacter pylori | 7 | ALA1649516 | organism-based format | Scientific Literature | |
10. | ALA1655025 | F | Antibacterial activity against Helicobacter pylori ARHp80 by CLSI M100-S13 method | Helicobacter pylori | 7 | ALA1649516 | organism-based format | Scientific Literature | |
11. | ALA1655026 | B | Inhibition of MurI in flaA mutant Helicobacter pylori Hp80.2 overexpressing MurI gene assessed as microbial growth inhibition by CLSI M100-S13 method | Helicobacter pylori | 7 | ALA1649516 | single protein format | Scientific Literature | |
12. | ALA1655027 | F | Antibacterial activity against HefC-deficient Helicobacter pylori ARHp80 by CLSI M100-S13 method | Helicobacter pylori | 7 | ALA1649516 | organism-based format | Scientific Literature | |
13. | ALA1655028 | F | Antibacterial activity against Escherichia coli by CLSI M100-S13 method | Escherichia coli | 7 | ALA1649516 | organism-based format | Scientific Literature | |
14. | ALA1655029 | F | Antibacterial activity against Staphylococcus aureus by CLSI M100-S13 method | Staphylococcus aureus | 7 | ALA1649516 | organism-based format | Scientific Literature | |
15. | ALA1655030 | F | Antibacterial activity against Streptococcus pneumoniae NCTC 7466 by CLSI M100-S13 method | Streptococcus pneumoniae | 3 | ALA1649516 | organism-based format | Scientific Literature | |
16. | ALA1655031 | F | Antibacterial activity against Enterococcus faecium ATCC 19434 by CLSI M100-S13 method | Enterococcus faecium | 3 | ALA1649516 | organism-based format | Scientific Literature | |
17. | ALA1655032 | F | Antibacterial activity against Haemophilus influenzae ATCC 51907 by CLSI M100-S13 method | Haemophilus influenzae | 3 | ALA1649516 | organism-based format | Scientific Literature | |
18. | ALA1655033 | F | Antibacterial activity against Moraxella catarrhalis ATCC 43617 by CLSI M100-S13 method | Moraxella catarrhalis | 3 | ALA1649516 | organism-based format | Scientific Literature |